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A B S T R A C T
Ethnopharmacological relevance: Kiwifruit is native to eastern China and many are the references about the
consumption of fruits and fruits extracts of the Actinidia plants in Chinese traditional medicine as therapeutic
food supplements to prevent and/or counteract numerous disorders including inflammation-related diseases like
cancer.
Aim of the study: Aim of the present work was to obtain a kiwifruit peel extract, rich in polyphenols, and to
explore the anti-inflammatory potential by analyzing its capability to target multiple pathways involved in
monocyte-mediated inflammatory response.
Materials and methods: The extract was obtained from the fruit peel of Actinidia deliciosa (A.Chev.) C.F.Liang &
A.R.Ferguson, cv Hayward and characterized by HPLC-DAD-ESI-MS. Lipopolysaccharide-stimulated THP-1
monocytes were used as a model of human inflammation in vitro.
Results: Analytical data evidenced that procyanidins resulted the main polyphenols present in the extract, re-
presenting the 92% w/w of the total. The extract inhibited the production of inflammatory molecules such as IL-
6, IL-1β, TNF-α pro-inflammatory cytokines, HMGB1 danger signal and granzyme B serine protease by activated
monocytes. In particular, an inhibitory activity of 81%, 68%, 63%, 76% and 60% on the extracellular release of
IL-6, IL-1β, TNF-α, HMGB1 and granzyme B, respectively, was observed by western blot analysis. Moreover, the
extract prevented STAT3 activation and promoted autophagy.
Conclusions: The reported findings demonstrated a strong and broad anti-inflammatory profile of the kiwifruit
peel extract, which makes it a promising preventive and therapeutic natural ingredient for nutraceutical, cos-
metic and pharmaceutical formulations to counteract multiple inflammatory disorders.
1. Introduction
Kiwifruit is the edible berry of the Actinidia plant (Actinidiaceae).
The most commonly consumed is the green berry of the Actinidia deli-
ciosa (A.Chev.) C.F.Liang & A.R.Ferguson, cv Hayward. According to
data provided by the Food and Agriculture Organization (FAO) of the
United States, kiwifruits cultivation is relevant in China (the native
country), Italy, New Zealand, Chile and Greece, which represent the
five largest producers in the world.
The use of kiwifruit in Chinese traditional medicine is well
documented since the 1400's C.E. while the first recorded reference on
the effects against a “cancer-like” disease dates even back to the 720's
B.C.E. (Motohashi et al., 2002; Singletary, 2012; Sun et al., 2012). Over
the years, kiwifruit has known an ever-wider use in traditional medi-
cine to prevent cardiovascular and degenerative diseases, to relieve
disorders caused from dyspepsia, rheumatism, digestive problems and
to treat stomach, liver and rectal cancer (Zhi, 1980; Yang, 1981).
More recently, several studies have been focused on the biological
activities of the kiwifruit, by individually analyzing extracts derived
from either the fruit (Motohashi et al., 2002; Hunter et al., 2011) or the
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peel (Motohashi et al., 2001; Yang et al., 2013; Lee et al., 2014).
However, to the best of our knowledge, the anti-inflammatory effects of
kiwifruit peel extract have never been investigated so far.
Inflammation is the body's normal response to injuries or infections,
but, when excessive or persistent, it causes and advances many serious
inflammatory diseases including cancer (Lansky and Newman, 2007;
Cragg et al., 2009; Martinez-Micaelo et al., 2012; Bernini et al., 2013,
2015). Monocytes and monocyte-derived cells represent critical players
in the orchestration of the inflammatory response, representing thus
key therapeutic targets for disease treatment. Several studies reported
that polyphenols (Andujar et al., 2011; Pietrocola et al., 2012; Bernini
et al., 2013, 2015; Rosillo et al., 2014; Liu et al., 2018), and, in parti-
cular, procyanidins exerted an anti-inflammatory activity (Bak et al.,
2013; De la Iglesia et al., 2010; Martinez-Micaelo et al., 2012).
Based on the consideration that the peel is intimately connected to
the pulp, which is the edible part of kiwifruits largely used in Chinese
traditional medicine, and the lack of the literature on the biological
activities of kiwifruits peel, the aim of this work was to investigate the
in vitro anti-inflammatory activity of a peel extract rich in polyphenols
obtained from Actinidia deliciosa on activated human THP-1 monocytes,
through the analysis of its capability to target multiple processes in-
volved in monocyte-mediated inflammation. Indeed, we investigated
the capability of the kiwifruit peel extract to inhibit the production of a
number of inflammatory mediators including interleukins (IL-6, IL-1β)
and tumor necrosis factor (TNF-α) pro-inflammatory cytokines, high
mobility group box 1 (HMGB1) danger signal and granzyme B serine
protease, to prevent the activation of STAT3 signaling and to promote
autophagy.
2. Material and methods
2.1. Plant material
Low-weight fruits Actinidia deliciosa (A.Chev.) C.F.Liang &
A.R.Ferguson, cv Hayward were collected from Stefano Della Bianca
orchard in Cisterna di Latina (Latina, Italy; Latitude: 41°31'42.8''N;
Longitude: 12°47'31.3''E) in July 2016. A representative of the cultivar
has been transplanted in the “Orto dei semplici” section of the “Angelo
Rambelli” Botanical Garden of the University of Tuscia, under the ac-
cession GS159.
2.2. Kiwifruit peel extract preparation and characterization
A kiwifruit peel extract rich in polyphenols was prepared according
to a procedure already optimized in our laboratory (Pinelli et al., 2013).
Briefly, the peel was isolated from fruits, weighed, frozen in liquid ni-
trogen and crushed in a mortar. 1 g of the resulting powder was ex-
tracted with 50mL of ethanol/ water = 70/30 v/v (water at pH 3.2)
under magnetic stirring at room temperature for 24 h. After cen-
trifugation of the mixture, the supernatant was recovered and stored at
− 20 °C.
The quali-quantitative characterization of polyphenols present in
the extract was carried out by HPLC-DAD-ESI-MS using a HP-1100 li-
quid chromatograph equipped with a DAD detector and a HP 1100 MSD
API-electrospray (Agilent Technologies) operating both in negative and
positive ionization mode and a column Zorbax SB-Aq 4.6mm ID ×
150mm (5 µm, Agilent) according to already reported in our laboratory
(Pinelli et al., 2013). Polyphenols were identified by retention times,
spectroscopic and MS data. Procyanidins and hydroxycinnamic acid
derivatives were quantified at 280 and 330 nm using catechin and
caffeic acid as reference standard, respectively. The quantitative de-
termination was carried out using five-point regression curves (with
r2> 0.9998). All determinations were carried out in triplicate.
Results are given as means and expressed as mg per gram of peel
(Table 1) considering that, each mL of extract is referred to 0.02 g of
kiwifruit peel; standard error was always< 5% (Pinelli et al., 2013).
For the biological activities, a stock solution of the extract solubi-
lized in ethanol/water= 70/30, corresponding to a concentration of
12mg/mL, was expressly prepared as briefly described. From a sample
of extract solution, the solvent was removed under reduced pressure by
a rotary evaporator (Heidolph, Germany) to afford a powder that was
weighted and solubilized with a known volume of ethanol/water= 70/
30 to obtain 12mg/mL (stock solution). Then, cells were incubated
with the indicated concentrations of the extract (25, 50, 100 and
200 μg/mL), by diluting the stock solution in the cell culture medium.
The final concentration of ethanol in the cell culture medium, for both
test and corresponding control experiment, was always< 1.6%, com-
patible with cell viability (assessed by the trypan blue dye exclusion
assay) and function (assessed by the analysis of cell proliferation).
2.3. Cell culture
THP-1 human monocytic cells, derived from a patient with acute
monocytic leukemia (AML), from American Type Culture Collection
(ATCC® TIB-202™; ATCC, MD, USA), were cultured in RPMI 1640
medium (Sigma-Aldrich, St. Louis, MO, USA) containing 10% FCS
(HyClone, Logan, UT, USA), 100 μg/mL of streptomycin and 100 IU/mL
penicillin; they were maintained in a 5% CO2 incubator at 37 °C. Cells
were mycoplasma free (EZ-PCR Mycoplasma test kit; Biological
Industries, Cromwell, CT, USA).
2.4. Cell treatments
For THP-1 activation, cells were cultured with 100 ng/mL lipopo-
lysaccharide (LPS) from Escherichia coli O55:B5 (L2880 Sigma) for
24 h. THP-1 cells were incubated with ethanolic solution alone
(Control) or with the extract, solubilized in ethanolic solution, at the
indicated doses, for the indicated times. For the autophagic investiga-
tion, THP-1 cells were cultured with the extract (50 μg/mL) for 24 h and
then treated with Bafilomycin A1 (Baf) (20 nM) (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA), an inhibitor of vacuolar-H
+-ATPase, for the last 2 h. In some experiments, 3-methyladenine (3-
MA) (0.2mM) (Santa Cruz Biotechnology Inc.) was added 2 h before the
extract treatment.
2.5. Antibodies
The following primary antibodies were used: rabbit polyclonal anti-
IL-6 (Gene Tex, Alton Pkwy Irvine, CA), rabbit polyclonal anti-IL-1β
(Gene Tex, CA, USA), mouse monoclonal anti-TNFα (Santa Cruz),
rabbit polyclonal anti-HMGB1 (Abcam, Cambridge, UK), mouse
monoclonal anti-granzyme B (Calbiochem, San Diego, CA, USA), mouse
monoclonal anti-phospho-STAT3 (pY705) (BD Transduction
Laboratories, San Jose, CA, USA), mouse monoclonal anti-STAT3 (BD
Transduction Laboratories), rabbit polyclonal anti-LC3 (Novus
Biologicals, Littleton, CO, USA), mouse monoclonal anti-p62 (BD
Transduction Laboratories) and mouse monoclonal anti-β-actin Ac-40
(Sigma-Aldrich).
2.6. Cell viability and proliferation assay
After each treatment, cell viability was assessed by the trypan blue
dye exclusion assay, as previously reported (D'Eliseo et al., 2017). The
analysis of cell proliferation was performed using 0.05% trypan blue
solution to count the number of live cells within a Neubauer chamber.
At least three replicate counts were conducted by the same operator at
each time.
2.7. Cytokine measurement
Cytokines were measured in conditioned media using the MILLIP-
LEX® MAP Human Cytokine/Chemokine Magnetic Bead panel
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(Millipore, Billerica, MA, USA) according to the manufacturer's in-
structions and detected by Bio-Plex® MAGPIX™ Multiplex Reader (Bio-
rad).
2.8. Western blot analysis
Cells were washed twice in PBS and cell lysates were prepared by a
solution containing 50mM TRIS-HCl pH 7.6, 150mM NaCl, 0.5%
TRITON X-100, 0.5% Sodium deoxycolate, 0.1% SDS and the protease
inhibitor mixture ‘‘Complete’’ (Roche Diagnostic GmbH, Mannheim,
Germany). For the experiments analyzing the extracellular release of
inflammatory mediators, the conditioned media was collected. Proteins
were separated by SDS-PAGE and blotted onto nitrocellulose mem-
branes (Whatman-Protan, Sigma-Aldrich). The membranes were
blocked with 5% Non-Fat Dry Milk (Bio-Rad, Hercules, CA, USA),
probed with specific primary antibodies overnight, at 4 °C, washed and
incubated with appropriated secondary antibodies. The reaction was
revealed by horseradish peroxidase (HRP)-coupled secondary reagents
(Bio-Rad) and developed by enhanced chemiluminescence (Amersham
ECL Western Blotting Detection Reagent, GE Healthcare, MI, Italy).
2.9. Densitometric analysis
The quantification of protein bands was performed by densitometric
analysis using Quantity One 1-D analysis software (Bio-Rad) and band
intensities (b.i., band volume/area x mean pixel intensity), normalized
for β-actin, as previously reported (D'Eliseo et al., 2017).
2.10. Statistical analysis
Student's t-test was applied for all analyses; p < 0.05 was con-
sidered significant. All experiments were performed at least three times.
3. Results and discussion
3.1. Kiwifruit peel extract preparation and characterization
The peel of the green berry of Actinidia deliciosa (A.Chev.) C.F.Liang
& A.R.Ferguson, cv Hayward was treated with ethanol/acidified water
(pH 3.2)= 70/30 v/v according to a procedure already optimized in
our laboratory (Pinelli et al., 2013) to obtain a polyphenolic-rich ex-
tract. The quali-quantitative analysis of the extract was performed by
HPLC-DAD-ESI-MS. As reported in Table 1, procyanidins dimers, tri-
mers and tetramers resulted the main class of polyphenols present in
the extract with 5.422 ± 0.209mg per gram of peel, representing the
92% w/w of the total; hydroxycinnamic acid derivatives covered the
remaining percentage (8% w/w) with 0.459 ± 0.015mg/g.
3.2. Effects of kiwifruit peel extract on THP-1 cell viability and proliferation
Kiwifruit peel extract was tested for cytotoxicity in THP-1 cells by
culturing them in the presence of increasing extract concentrations
(from 12.5 to 200 μg/mL) for 24 h. The trypan-blue dye exclusion assay
showed that the extract did not affect the viability of THP-1 cells at
none of the concentrations tested (Fig. 1A). Moreover, the evaluation of
cell growth showed that the cell number was not affected up to an
extract concentration of 100 μg/mL and then decreased in a dose de-
pendent manner (Fig. 1B), suggesting that a proliferative arrest might
occur at high concentrations. Thus, all subsequent experiments were
performed treating THP-1 cells with a dose of 50 μg/mL for 24 h.
Table 1
Quali-quantitative analysis of phenolic compounds found in the kiwifruit peel extract.
Compound tR (min) MW Negative ions (m/z)a λmax, λmin mg/gb
6-Hydroxy-7-(β-D-glucopiranolyloxy coumarin 10.9 340 339, 177 Traces
Caffeic acid derivative 14.0 356 355, 297, 239, 179, 161, 135 326, 264 0.243 ± 0.007
Ferulic acid glucoside 16.2 356 355, 193 312, 255 0.174 ± 0.006
Ferulic acid dehydrodimer 17.5 370 369, 193, 179, 135 324, 265 0.042 ± 0.002
Dimethyl caffeic acid hexoside 16.9 370 369, 207, 191 Traces
Procyanidin trimer 17.8 866 865, 577, 289 280, 258 1.193 ± 0.042
Procyanidin trimer 20.2 866 865, 577, 289 280, 258 0.659 ± 0.025
Procyanidin trimer 21.8 866 865, 577, 289 280, 258 0.665 ± 0.019
Procyanidin tetramer 24.2 1154 1153, 865, 577, 289 280, 258 0.142 ± 0.003
Procyanidin trimer 26.1 866 865, 577, 289 280, 258 0.880 ± 0.035
Procyanidin trimer 27.1 866 865, 577, 289 280, 258 1.187 ± 0.047
Procyanidin dimer 39.9 578 577, 289 280, 258 0.696 ± 0.038
Total hydroxycinnamic derivatives 0.459 ± 0.015
Total procyanidins 5.422 ± 0.209
Total polyphenols 5.881 ± 0.224
a m/z of the most abundant ESI/MS signals (fragmentor: 120 eV).
b mg of phenolic compound per gram of peel.
Fig. 1. Effects of kiwifruit peel extract on THP-1 cell viability (a) and pro-
liferation (b) at 24 h of treatment. Data show mean of the percentage (%) plus
S.D. of three independent experiments; *p < 0.005.
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3.3. Kiwifruit peel extract inhibited LPS-inducible and constitutive IL-6, IL-
1β and TNF-α production
Pro-inflammatory cytokines IL-6, IL-1β and TNF-α play a pivotal
role in the progression of the inflammatory process as a result of
monocyte activation. We, therefore, investigated the capability of the
extract to affect the production of the three cytokines by activated
monocytes. To this purpose, LPS-stimulated and unstimulated (Control)
THP-1 cells were treated with the extract and the protein levels of IL-6,
IL-1β and TNF-α were measured by Western blot analysis and nor-
malized for β-actin or Ponceau stain. Since it has been previously re-
ported that the maximum of TNF-α release is at earlier times compared
to IL-6 and IL-1β, we analyzed the release of TNF-α at 4 h, whereas IL-6
and IL-1β releases were measured at 24 h after treatment. Basal levels of
both intracellular and extracellular cytokines were detected in un-
stimulated THP-1 cells, and, as expected, they increased when THP-1
cells were stimulated with LPS (100 ng/mL) (Fig. 2A and B). However,
when the cell cultures were treated with the extract, an almost com-
plete reduction of the intracellular content (Fig. 2A) associated to a
significant decrease of the release (Fig. 2B) of all the three cytokines
was observed in both LPS-stimulated and unstimulated THP-1 cells.
Moreover, the inhibition of monocyte-mediated release of cytokines by
the extract was confirmed by Luminex multiplex assay (Fig. 2C). These
results showed that the kiwifruit peel extract suppressed the production
of pro-inflammatory cytokines, indicating a potential anti-in-
flammatory activity by the extract on inflammatory monocytes.
3.4. Kiwifruit peel extract inhibited LPS-inducible and constitutive HMGB1
production
Extracellular HMGB1 release by the inflammatory microenviron-
ment is involved in the pathogenesis of multiple human inflammatory
diseases (e.g., trauma, ischemia, chronic inflammatory disorders, au-
toimmune diseases and cancer), representing a key molecular target in
these diseases (Bianchi and Manfredi, 2007). Thus, we investigated the
capability of the extract to modulate HMGB1 production by activated
monocytes. We found that both the intracellular content (Fig. 2A) and
the extracellular release (Fig. 2B, right panel) of HMGB1 were sig-
nificantly inhibited by the extract in both LPS-stimulated and un-
stimulated THP-1 cells. This finding further supports the potential of
this extract for anti-inflammatory activity and, to the best of our
knowledge, this activity has never been described before in studies
investigating the anti-inflammatory capability of kiwifruits.
3.5. Kiwifruit peel extract inhibited LPS-inducible and constitutive
granzyme B production
The serine protease granzyme B is implicated in extracellular
functions involved in inflammation, cytokine activation and auto-
immunity, and elevated levels of soluble granzyme B have been re-
ported in plasma of patients with inflammatory diseases (Hiebert and
Granville, 2012). To notice, it has been demonstrated that monocytes/
macrophages express granzyme B in the lesion areas of inflammatory
Fig. 2. Effects of kiwifruit peel extract on the intracellular content (a) and the extracellular release (b, c) of inflammatory mediators by THP-1 cells. Data show
Western blot on cell lysates (a) and conditioned media (b); β-Actin and Ponceau staining served as intracellular and extracellular loading control, respectively;
numbers indicate band intensities (b.i.)= band volume/area x mean pixel intensity, normalized for β-actin or Ponceau staining and quantified using Quantity One 1-
D analysis software; representative experiments out of three. Histograms represent the mean plus S.D. of cytokine concentrations of three independent experiments,
evaluated in conditioned media by Luminex multiplex assay, (c); *p < 0.005.
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diseases, including atherosclerosis and rheumatoid arthritis. Thus, tar-
geting granzyme B provides new pharmaceutical agents for in-
flammatory disorders. Therefore, we analyzed whether the extract
could affect the production of granzyme B by THP-1 cells. We found
that the extract significantly inhibited both the intracellular expression
(Fig. 2A) and the extracellular release (Fig. 2B, right panel) of granzyme
B by LPS-stimulated and unstimulated THP-1 cells. This is the very first
time that a kiwifruit extract has been reported to mediate this activity.
This finding further supports the interest in this extract for its anti-
inflammatory potential.
3.6. Kiwifruit peel extract prevented STAT3 activation
STAT3 activation by pathogens, growth factors or cytokines, such as
IL-6, induces the production of pro-inflammatory cytokines and reg-
ulates diverse inflammatory processes, cell proliferation and survival
(Yu et al., 2009). In particular, STAT3 activation in monocytes con-
tributes to neovascular age-related macular degeneration (Chen et al.,
2016), as well as, promotes liver tumorigenesis (Wu et al., 2011). In-
deed, STAT3 in inflammatory monocytes appears a promising target for
pharmacological intervention in the prevention and treatment of the
development of inflammatory diseases and cancer (Yu et al., 2009).
Thus, we examined the capability of the extract to modulate STAT3
activation, by analyzing its phosphorylation at Tyr 705. As expected,
STAT3 phosphorylation (p-STAT3) levels significantly increased when
THP-1 cells were exposed to LPS (Fig. 3). However, treatment with the
extract significantly inhibited p-STAT3 in LPS-stimulated as well as in
unstimulated THP-1 cells (Fig. 3). Moreover, considering that STAT3
signaling is triggered by IL-6 upon interaction with IL-6 receptor, we
can suppose that a correlation exists between the inhibition of IL-6
production (Fig. 2) and the inhibition of STAT3 activation (Fig. 3).
Inhibition of IL-6 production and STAT3 activation by the extract are
both relevant findings, since numerous studies demonstrated the asso-
ciation of down-regulation of IL-6 and/or IL-6 signaling (i.e., STAT3)
with therapeutic results in inflammatory diseases. In addition, an im-
portant role of STAT3 has been identified in the development of dif-
ferent cancers, including AML (Redell et al., 2011). Therefore, our re-
sult, showing the inhibition of the constitutive level of STAT3 in
unstimulated THP-1 monocytic leukemia cells, suggests that the extract
might also exert anti-cancer activity in AML. Considering all these
findings, we think that the extract might represent a potential pro-
mising candidate to target the IL-6/STAT3 pathway in inflammatory
diseases and cancer.
3.7. Kiwifruit peel extract promoted autophagy
Autophagy mediates the clearance of cytoplasmic molecules, orga-
nelles and pathogens, and, interestingly, orchestrates inflammation,
immunity and cancer (Levine et al., 2011). In particular, activation of
autophagy in monocytes exerts anti-inflammatory activity, affecting
inflammatory cytokine production by different mechanisms, including
the inhibition of inflammasomes, leading to the suppression of IL-1β
and IL-18 maturation. Therefore, we examined whether the kiwifruit
peel extract could affect autophagy in THP-1 cells. To investigate the
autophagic process, two main autophagic markers such as the micro-
tubule-associated protein 1 light chain 3 (LC3) and the sequestosome-1
(SQSTM1)/ubiquitin-binding protein p62 were evaluated by Western
blot (Klionsky, 2016; D'Eliseo et al., 2017). During autophagy, LC3 is
processed post-translationally into soluble LC3-I and, in turn, converted
to membrane-bound LC3-II that correlates with the extent of autopha-
gosomes. Therefore, we identified LC3 in the LC3-II form in THP-1 cells
and, as shown in Fig. 4, LC3II formation significantly increased after
treatment with the extract, suggesting induction of autophagy. More-
over, we observed a further accumulation of LC3-II when extract-
treated cells were cultured in the presence of the vacuolar H+-ATPase
inhibitor bafilomycin A1 (Baf), confirming the induction of a complete
autophagic flux by the extract (Fig. 4). Furthermore, the addition of 3-
MA autophagic inhibitor to extract-treated THP-1 cells decreased LC3II
formation, confirming thus that LC3II protein levels were the result of
the autophagic process (Fig. 4). Then, we analyzed the other autophagic
marker such as SQSTM1/p62, which, being part of the assembled au-
tophagosome subsequently degraded in autolysosomes, serves as an
index of autophagic degradation. As shown in Fig. 4, SQSTM1/p62
levels decresed in THP-1 cells treated with the extract, further in-
dicating that the extract was able to promote a complete autophagic
process. This is a very significant finding, since defects in autophagy
have been linked to a wide range of diseases (e.g., cardiomyopathy,
neurodegenerative disorders, cancers), and compounds capable of in-
ducing autophagy have been recently received attention for the treat-
ment of inflammatory diseases (Levine et al., 2011).
4. Conclusions
In summary, this study has proved for the first time that an extract
rich in procyanidins, obtained from the peel of kiwifruits, is a sup-
pressor of the production of a number of inflammatory mediators such
as pro-inflammatory cytokines, HMGB1, granzyme B and STAT3 and a
promoter of autophagy on activated human THP-1 monocytes. These
results are consistent with reports demonstrating that polyphenols from
different origin are endowed with the inhibition of pro-inflammatory
cytokine production (Rosillo et al., 2014), the suppression of STAT3
Fig. 3. Effect of kiwifruit peel extract on STAT3 activation in THP-1 cells. Data
show STAT3 Tyr705 phosphorylation (p-STAT3), evaluated by western blot
(left panel); total STAT3 and β-actin served as controls; numbers indicate band
intensities (b.i.)= band volume/area x mean pixel intensity, normalized for β-
actin and quantified using Quantity One 1-D analysis software; representative
experiment out of three. Histograms represent the percentage (%), respect to
the control, of the mean plus S.D. of the densitometric analysis of p-STAT3/β-
actin ratio of three different experiments (right panel); *p < 0.005.
Fig. 4. Effect of kiwifruit peel extract on autophagy in THP-1 cells. Data show
the expression of LC3I/II and SQSTM1/p62 autophagic markers, analyzed by
western blot (left panel); β-actin was included as loading control; numbers
indicate band intensities (b.i.) = band volume/area x mean pixel intensity,
normalized for β-actin and quantified using Quantity One 1-D analysis soft-
ware; representative experiment out of three. Histograms represent the mean
plus S.D. of the densitometric analysis of LC3II/β-actin and p62/β-actin ratio of
three independent experiments (right panel); *p < 0.005.
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activation (Andujar et al., 2011) and the promotion of autophagy
(Pietrocola et al., 2012). All the data show that the extract may re-
present a potential promising anti-inflammatory natural ingredient for
pharmaceutical and nutraceutical formulations. However, this as-
sumption requires further verification using in vivo models.
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